Home ›
NPI 1124130653
NPI deactivated
1124130653
1124130653 was paid $15.23M by Medicaid between Jan 2018 and Apr 2022, across 134 billing codes. Its largest line is 87799, — 25% of everything it billed.
33Billing provider info1124130653
33aNPI1124130653
33bProvider type—
28Total paid$15.23M
24GClaims410,772
24DCodes billed134
24AFirst – last monthJan 2018 – Apr 2022
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,476 | $1.39M | |
| 2019 | 58,081 | $1.92M | |
| 2020 | 137,319 | $5.74M | |
| 2021 | 157,792 | $6.10M | |
| 2022 | 2,104 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87799 | 25% | 63,154 | 36,153 | $3.82M | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 11% | 43,359 | 38,036 | $1.74M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.8% | 40,463 | 35,311 | $1.34M |
| 87902 | 8.8% | 7,847 | 7,189 | $1.34M | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.8% | 40,559 | 35,240 | $1.34M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.6% | 19,128 | 17,927 | $1.31M |
| 87512 | 7.7% | 40,629 | 35,330 | $1.18M | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5.9% | 41,415 | 36,843 | $896K |
| 87901 | 2.1% | 3,793 | 3,466 | $319K | |
| 87522 | Neg quan hep c or qual rna | 1.9% | 8,136 | 7,678 | $293K |
| 87900 | 1.6% | 3,811 | 3,479 | $241K | |
| 87536 | 1.5% | 5,680 | 5,400 | $236K |
122 more codes
| 86696 | 1.1% | 10,977 | $175K | |
| 87906 | <1% | 2,031 | $130K | |
| 86695 | <1% | 9,801 | $105K | |
| 87529 | <1% | 2,215 | $91K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,624 | $77K |
| 86787 | <1% | 6,197 | $68K | |
| 87517 | <1% | 2,245 | $65K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,346 | $41K |
| 86753 | <1% | 5,341 | $32K | |
| 87497 | <1% | 945 | $29K | |
| 86317 | <1% | 6,089 | $25K | |
| 86682 | <1% | 2,834 | $24K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 643 | $23K |
| 87521 | Neg quan hep c or qual rna | <1% | 884 | $23K |
| 87912 | <1% | 372 | $21K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 811 | $18K |
| 86635 | <1% | 724 | $18K | |
| 87631 | <1% | 174 | $16K | |
| 87632 | <1% | 183 | $15K | |
| 86780 | <1% | 2,272 | $15K | |
| 86628 | <1% | 947 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 711 | $10K |
| 87535 | <1% | 309 | $9K | |
| 86665 | <1% | 734 | $8K | |
| 86382 | <1% | 604 | $8K | |
| 83520 | <1% | 736 | $8K | |
| 87563 | <1% | 489 | $8K | |
| 87254 | <1% | 577 | $7K | |
| 87481 | <1% | 403 | $7K | |
| 87230 | <1% | 556 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 103 | $7K |
| 82397 | <1% | 955 | $6K | |
| 86790 | <1% | 1,310 | $6K | |
| 86794 | <1% | 322 | $6K | |
| 87081 | <1% | 933 | $6K | |
| 87634 | <1% | 201 | $5K | |
| 86774 | <1% | 530 | $5K | |
| 86592 | <1% | 1,614 | $4K | |
| 86707 | <1% | 381 | $3K | |
| 86765 | <1% | 372 | $3K | |
| 87350 | <1% | 398 | $3K | |
| 86747 | <1% | 193 | $3K | |
| 86692 | <1% | 435 | $3K | |
| 87109 | <1% | 259 | $2K | |
| 86757 | <1% | 264 | $2K | |
| 86664 | <1% | 437 | $2K | |
| 86618 | <1% | 691 | $2K | |
| 86648 | <1% | 291 | $2K | |
| 86803 | <1% | 568 | $2K | |
| 86735 | <1% | 321 | $2K | |
| 86617 | <1% | 394 | $2K | |
| 86666 | <1% | 876 | $2K | |
| 86762 | <1% | 347 | $2K | |
| 86615 | <1% | 122 | $2K | |
| 87340 | <1% | 429 | $1K | |
| 86611 | <1% | 157 | $1K | |
| 86644 | <1% | 277 | $1K | |
| 86638 | <1% | 140 | $1K | |
| 87300 | <1% | 200 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 712 | $1K |
| 87150 | <1% | 39 | $898.95 | |
| 86769 | <1% | 22 | $733.16 | |
| 87538 | <1% | 37 | $715.46 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,233 | $642.32 |
| 87449 | <1% | 90 | $614.79 | |
| 86645 | <1% | 139 | $577.41 | |
| 86738 | <1% | 82 | $539.16 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 695 | $375.10 |
| 80053 | Comprehensive metabolic panel | <1% | 1,358 | $329.53 |
| 87168 | <1% | 218 | $272.87 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 897 | $257.95 |
| 86684 | <1% | 22 | $257.68 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,386 | $245.22 |
| 86609 | <1% | 29 | $231.80 | |
| 87280 | <1% | 15 | $229.20 | |
| 82607 | <1% | 441 | $143.49 | |
| 80061 | Lipid panel | <1% | 686 | $127.78 |
| 86038 | <1% | 376 | $127.26 | |
| 83014 | <1% | 30 | $116.37 | |
| 83516 | <1% | 156 | $108.12 | |
| 86658 | <1% | 15 | $103.05 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 611 | $95.40 |
| 82784 | <1% | 169 | $94.06 | |
| 86140 | <1% | 387 | $63.30 | |
| 86663 | <1% | 12 | $60.11 | |
| 86403 | <1% | 13 | $55.65 | |
| 82746 | <1% | 258 | $51.13 | |
| 86704 | <1% | 116 | $47.55 | |
| 84439 | <1% | 258 | $47.31 | |
| 86255 | <1% | 69 | $43.84 | |
| 82728 | <1% | 133 | $36.95 | |
| 86706 | <1% | 131 | $36.69 | |
| 85652 | <1% | 360 | $35.70 | |
| 86060 | <1% | 148 | $33.82 | |
| 87186 | <1% | 27 | $28.15 | |
| 81001 | <1% | 408 | $22.12 | |
| 82043 | <1% | 65 | $21.00 | |
| 83540 | <1% | 234 | $20.92 | |
| 82248 | <1% | 236 | $20.80 | |
| 86431 | <1% | 116 | $20.29 | |
| 83550 | <1% | 144 | $20.03 | |
| 82570 | <1% | 70 | $18.76 | |
| 82105 | <1% | 85 | $17.40 | |
| 86622 | <1% | 21 | $12.10 | |
| 82977 | <1% | 62 | $11.19 | |
| 84550 | <1% | 87 | $9.36 | |
| 83735 | <1% | 43 | $6.94 | |
| 81003 | <1% | 73 | $4.64 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 39 | $4.18 |
| 83615 | <1% | 12 | $3.13 | |
| 84100 | <1% | 52 | $2.46 | |
| 84436 | 0% | 135 | $0.00 | |
| 84153 | 0% | 25 | $0.00 | |
| 84479 | 0% | 26 | $0.00 | |
| 80197 | 0% | 26 | $0.00 | |
| 86671 | 0% | 18 | $0.00 | |
| 86021 | 0% | 21 | $0.00 | |
| 82465 | 0% | 14 | $0.00 | |
| 80074 | 0% | 26 | $0.00 | |
| 86708 | 0% | 72 | $0.00 | |
| 86709 | 0% | 12 | $0.00 | |
| 86200 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.